Bottom Line:
Author: Robbert Zusterzeel, M.D., and colleagues at the Center for Devices and Radiological Health at the U.S. Food and Drug Administration, Silver Spring, Md.
Background:
How the Study Was Conducted:
Results:
Discussion:
( JAMA Intern Med . Published online June 23, 2014. doi:10.1001/jamainternmed.2014.2717. Available pre-embargo to the media at http://media.jamanetwork.com .)
Editor's Note:
Commentary: The Case for Sex- and Gender-Specific Medicine
In a related commentary, C. Noel Bairey Merz, M.D., of the Cedars Sinai Heart Institute, Los Angeles, Calif., and Vera Regitz-Zagrosek, M.D., of Charite University Medicine, Berlin, write: "There are numerous differences in cardiovascular disease (CVD) between men and women. … There are also important sex differences in use of cardiac devices."
"These results also shed light on a major contributor to the misdiagnosis and suboptimal treatment of CVD in women: guidelines are typically based on a male standard and do not address important differences in women."
( JAMA Intern Med . Published online June 23, 2014. doi:10.1001/jamainternmed.2014.320. Available pre-embargo to the media at http://media.jamanetwork.com .)
Media Advisory: To contact corresponding author David G. Strauss, M.D., Ph.D., call Susan Laine at 301-796-5349 or email Susan.Laine@fda.hhs.gov . To contact commentary author C. Noel Bairey Merz, M.D., call Sally Stewart 310-248-6566 or email sally.stewart@cshs.org .
JAMA Internal Medicine